Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 6.02% is 234% above its 5-year average of -4.50%, near the high end of its 5-year range (-23.69%–17.14%).
57.57% above its 12-month average of 3.82%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -0.26%.
OPERATING MARGIN
6.02%
OPERATING MARGIN AVG TTM
3.82%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
-4.50%
OPERATING MARGIN AVG 10Y
-22.60%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+57.57%
CURRENT VS 3Y AVG
+162734.62%
CURRENT VS 5Y AVG
+233.78%
CURRENT VS 10Y AVG
+126.63%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
13.39%
median of 102 covered companies
CURRENT VS SECTOR MEDIAN
-55.06%
vs the sector median at left
Inspire Medical Systems, Inc.
Market Cap
$2.02B
Operating Margin
6.02%
TTM Avg
3.82%
3Y Avg
0.00%
5Y Avg
-4.50%
Market Cap
$1.90B
Operating Margin
0.41%
TTM Avg
-3.56%
3Y Avg
0.15%
5Y Avg
-1.31%
Market Cap
$2.16B
Operating Margin
-867.87%
TTM Avg
-840.98%
3Y Avg
-774.76%
5Y Avg
-1234.34%
Market Cap
$1.74B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$1.71B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$2.52B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
Market Cap
$2.76B
Operating Margin
12.21%
TTM Avg
13.21%
3Y Avg
-4.78%
5Y Avg
-42.05%
Market Cap
$1.00B
Operating Margin
-6.98%
TTM Avg
-25.06%
3Y Avg
-156.73%
5Y Avg
-114.38%
Market Cap
$474.59M
Operating Margin
-8.63%
TTM Avg
-11.52%
3Y Avg
-18.04%
5Y Avg
-16.64%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | $2.02B | 6.02% | 3.82% | 0.00% | -4.50% |
| Fortrea Holdings Inc. (FTRE)vs › | $1.90B | 0.41% | -3.56% | 0.15% | -1.31% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | -867.87% | -840.98% | -774.76% | -1234.34% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 11.69% | -8.16% | -10.59% | -4.68% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | -651.67% | -787.38% | -968.58% | -820.03% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | -274.57% | -464.41% | -382.79% | -92575.80% |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 12.21% | 13.21% | -4.78% | -42.05% |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -6.98% | -25.06% | -156.73% | -114.38% |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | -8.63% | -11.52% | -18.04% | -16.64% |
| NRC Health (NRC)vs › | $458.62M | 10.53% | 20.52% | 24.67% | 27.45% |
Gross Margin
86.1%
Operating Margin
6.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -0.26% |
| 2026-03-31 | -0.55% |
| 2025-12-31 | 17.14% |
| 2025-09-30 | 4.30% |
| 2025-06-30 | -1.53% |
| 2025-03-31 | -0.74% |
| 2024-12-31 | 13.30% |
| 2024-09-30 | 7.05% |
| 2024-06-30 | 2.60% |
| 2024-03-31 | -9.28% |
| 2023-12-31 | 4.83% |
| 2023-09-30 | -8.79% |
| 2023-06-30 | -10.99% |
| 2023-03-31 | -15.25% |
| 2022-12-31 | -0.24% |
| 2022-09-30 | -15.75% |
| 2022-06-30 | -15.33% |
| 2022-03-31 | -23.14% |
| 2021-12-31 | -2.32% |
| 2021-09-30 | -15.88% |
| 2021-06-30 | -23.69% |
| 2021-03-31 | -38.88% |
| 2020-12-31 | -15.35% |
| 2020-09-30 | -27.60% |
| 2020-06-30 | -187.26% |
| 2020-03-31 | -77.01% |
| 2019-12-31 | -34.54% |
| 2019-09-30 | -41.47% |
| 2019-06-30 | -45.34% |
| 2019-03-31 | -54.01% |
| 2018-12-31 | -29.57% |
| 2018-09-30 | -35.61% |
| 2018-06-30 | -51.54% |
| 2018-03-31 | -51.73% |
| 2017-12-31 | -38.63% |
| 2017-09-30 | -50.19% |
| 2017-06-30 | -72.56% |
| 2017-03-31 | -77.86% |
